Eurobio Scientific SA (ALERS)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 25.20 |
|---|---|
| 52-week range | 19.20 – 25.50 |
| Return, 1 month / 3 months | +0.0% / +19.4% |
| Return, 1 year / 3 years | +3.9% / +66.0% |
| Trend | Uptrend |
| RSI (14) | 71 |
| Volatility (1 year) | 36.0% |
| Worst drawdown (1 year) | -22.7% |
| Average daily value traded | 0.10M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eurobio Scientific is a French in vitro diagnostics company based near Paris. It designs, manufactures and markets diagnostic test kits and reagents used by hospital laboratories and clinical testing services, with a focus on infectious disease testing and transplantation monitoring. The company also distributes specialised life science products and instruments to research and clinical customers, combining its own branded tests with products sourced from partner manufacturers for laboratories in France and other markets.
The shares are listed on the Euronext Paris in France under the code ALERS, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eurobio Scientific SA (ALERS) trades on the Euronext Paris in France. It last closed at EUR 25.20 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 45 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.9% and over the last three months it rose 19.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.7% | ||
| From 52-week high | -0.4% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.4% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | 3.9% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.7% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.10M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +19.4% |
| 6 months | +10.5% |
| 1 year | +3.9% |
| 3 years | +66.0% |
| 5 years | +38.3% |
Signals
| 50-day / 200-day average | 22.82 / 22.56 |
|---|---|
| Golden / death cross (60 days) | Golden, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.27 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.